It was reported on (b)(6) 2019, that a (b)(6) male patient, who was enrolled in (b)(6) clinical study, underwent an epicardial portion of the procedure on (b)(6) 2019 and was discharged from the hospital on (b)(6) 2019.During a follow-up visit on (b)(6) 2019, patient presented with significant fluid retention.An ultrasound was conducted which revealed pleural effusion.The patient was prescribed medication bumex 1 mg.On (b)(6) 2019, the patient presented with weight loss and complained of shortness of breath when walking.A thoracentesis was performed, 1000 ml serosanguineous fluid was drained.The surgeon assessed the adverse event of pleural effusion as related to patient¿s intercurrent condition and not related to the device or procedure.Current status of the patient, the pleural effusion is resolved, and the patient is doing well.This is a procedure related complication.There was no reported device malfunction.
|